Viraleze marketing, page-107

@witt I have literally spoon fed you and a few others my considered and researched opinions but more importantly, exact quotes from our CEO. I deduce from your post that you have either not read my posts in full or just still don’t understand or comprehend. I cannot make it any simpler.

Our CEO stated that once we get European and UK approval (not rollout), Starpharma will submit Viraleze to the TGA. It appears that almost 7 weeks later they still haven’t. And I’ve detailed previously why the optics of getting TGA approval is important. I’m not going to waste my time and repeat it just for you.

And the cost to submit Viraleze to the TGA is pretty much insignificant. You must be joking that we would be ‘wasting money’. Jackie raised almost $49 million of our money last year of which some of this massive capital raise was to go to the accelerated development, regulatory and commercialisation activities for the Covid nasal spray.